Moore Jeremy P, de Groot Natasja M S, O'Connor Matthew, Cortez Daniel, Su Jonathan, Burrows Austin, Shannon Kevin M, O'Leary Edward T, Shah Maully, Khairy Paul, Atallah Joseph, Wong Tom, Lloyd Michael S, Taverne Yannick J H J, Dubin Anne M, Nielsen Jens C, Evertz Reinder, Czosek Richard J, Madhavan Malini, Chang Philip M, Aydin Alper, Cano Óscar
Division of Cardiology, Ahmanson/UCLA Adult Congenital Heart Disease Center, Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, California, USA; Cardiac Arrhythmia Center, UCLA Health System, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA; Division of Cardiology, Department of Pediatrics, UCLA Medical Center, Los Angeles, California, USA.
Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands.
JACC Clin Electrophysiol. 2023 Mar;9(3):385-393. doi: 10.1016/j.jacep.2022.10.012. Epub 2022 Nov 30.
Dyssynchrony-associated left ventricular systolic dysfunction is a major contributor to heart failure in congenital heart disease (CHD). Although conventional cardiac resynchronization therapy (CRT) has shown benefit, the comparative efficacy of cardiac conduction system pacing (CSP) is unknown.
The purpose of this study was compare the clinical outcomes of CSP vs conventional CRT in CHD with biventricular, systemic left ventricular anatomy.
Retrospective CSP data from 7 centers were compared with propensity score-matched conventional CRT control subjects. Outcomes were lead performance, change in left ventricular ejection fraction (LVEF), and QRS duration at 12 months.
A total of 65 CSP cases were identified (mean age 37 ± 21 years, 46% men). The most common CHDs were tetralogy of Fallot (n = 12 [19%]) and ventricular septal defect (n = 12 [19%]). CSP was achieved after a mean of 2.5 ± 1.6 attempts per procedure (38 patients with left bundle branch pacing, 17 with HBP, 10 with left ventricular septal myocardial). Left bundle branch area pacing [LBBAP] vs HBP was associated with a smaller increase in pacing threshold (Δ pacing threshold 0.2 V vs 0.8 V; P = 0.05) and similar sensing parameters at follow-up. For 25 CSP cases and control subjects with baseline left ventricular systolic dysfunction, improvement in LVEF was non-inferior (Δ LVEF 9.0% vs 6.0%; P = 0.30; 95% confidence limits: -2.9% to 10.0%) and narrowing of QRS duration was more pronounced for CSP (Δ QRS duration 35 ms vs 14 ms; P = 0.04). Complications were similar (3 [12%] CSP, 4 [16%] conventional CRT; P = 1.00).
CSP can be reliably achieved in biventricular, systemic left ventricular CHD patients with similar improvement in LVEF and greater QRS narrowing for CSP vs conventional CRT at 1 year. Among CSP patients, pacing electrical parameters were superior for LBBAP vs HBP.
不同步相关的左心室收缩功能障碍是先天性心脏病(CHD)患者发生心力衰竭的主要原因。尽管传统心脏再同步治疗(CRT)已显示出益处,但心脏传导系统起搏(CSP)的相对疗效尚不清楚。
本研究旨在比较CSP与传统CRT在具有双心室、系统性左心室解剖结构的CHD患者中的临床结局。
将来自7个中心的回顾性CSP数据与倾向评分匹配的传统CRT对照受试者进行比较。结局指标为12个月时的导线性能、左心室射血分数(LVEF)变化和QRS时限。
共确定65例CSP病例(平均年龄37±21岁,46%为男性)。最常见的CHD类型为法洛四联症(n = 12 [19%])和室间隔缺损(n = 12 [19%])。每次手术平均尝试2.5±1.6次后成功实现CSP(38例患者为左束支起搏,17例为希氏束起搏,10例为左心室间隔心肌起搏)。左束支区域起搏[LBBAP]与希氏束起搏相比,起搏阈值升高幅度较小(起搏阈值变化0.2V对0.8V;P = 0.05),随访时感知参数相似。对于25例基线存在左心室收缩功能障碍的CSP病例和对照受试者,LVEF的改善无劣效性(LVEF变化9.0%对6.0%;P = 0.30;95%置信区间:-2.9%至10.0%),CSP组QRS时限缩窄更明显(QRS时限变化35ms对14ms;P = 0.04)。并发症相似(CSP组3例[12%],传统CRT组4例[16%];P = 1.00)。
在具有双心室、系统性左心室的CHD患者中,CSP可可靠实现,1年时LVEF改善相似,与传统CRT相比,CSP组QRS缩窄更明显。在CSP患者中,LBBAP的起搏电参数优于希氏束起搏。